Prenatal SSRI use is linked to reduced head growth in study

03/5/2012 | Yahoo! · DailyRx.com

Babies born to mothers who took selective serotonin reuptake inhibitors were more likely to have reduced head growth, a Dutch study found. Mothers with untreated depression were more likely to give birth to babies with overall reduced growth. Researchers also found that mothers who used SSRIs had a higher risk of preterm birth compared with mothers without depression. The findings appear in the Archives of General Psychiatry.

View Full Article in:

Yahoo! · DailyRx.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC